Search | IOVS | ARVO Journals

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Individualizing therapy for neovascular age-related macular degeneration with aflibercept (the VITAL study): A two year prospective, interventional single-centre trial

Simona Degli Esposti; Maria K Gemenetzi; Maria Eleftheriadou; Hari Jayaram; Bishwanath Pal; Niaz Islam; Peter Addison; Robin Hamilton; Praveen Patel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):85. doi:

ARVO Annual Meeting Abstract July 2019

Real–life evidence for using a treat-and-extend injection regime for patients with central retinal vein occlusion.

Maria Eleftheriadou; Luke Nicholson; Giulia D'Alonzo; Peter Addison

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2584. doi:

ARVO Annual Meeting Abstract July 2018

Prevalence of thickened choroid in eyes with a CNVM -an indicator for long term treatment.

Sumita Phatak; Maria Eleftheriadou; Rita Anjos-Serrano; Bish Pal

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2399. doi:

ARVO Annual Meeting Abstract July 2018

Prevalence and Progression of Retinal Pigment Epithelium and Outer Retinal Atrophy in Patients With Neovascular Age-Related Macular Degeneration in the Fellow Eye

Maria Eleftheriadou; Maria K Gemenetzi; Robyn H Guymer; Praveen Patel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3244. doi:

ARVO Annual Meeting Abstract June 2017

Optical coherence tomography angiography in treated neovascular age related macular degeneration

Maria K Gemenetzi; Maria Eleftheriadou; Adam Dubis; Simona Degli Esposti; Zaria Ali; Daren Hanumunthadu; Konstantinos Balaskas; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):46. doi:

ARVO Annual Meeting Abstract June 2017

Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular Degeneration

Maria Eleftheriadou; Maria K Gemenetzi; Sobha Sivaprasad; Philip G Hykin; Robin Hamilton; Adnan Tufail; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):874. doi:

ARVO Annual Meeting Abstract June 2017

1 year-Real world clinical audit of aflibercept use in the management of macular edema secondary to central retinal vein occlusion at Moorfields Eye Hospital

Eleni Vrizidou; Maria Eleftheriadou; Fani Zacharaki; Peter Addison

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1554. doi:

ARVO Annual Meeting Abstract September 2016

Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Maria Eleftheriadou; Clara Vazquez-Alfageme; Luke Nicholson; Sobha Sivaprasad; Philip Hykin; Robin D Hamilton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3342. doi:

ARVO Annual Meeting Abstract September 2016

Efficacy of Aflibercept in Treatment-naïve Neovascular Age-related Macular Degeneration: Two-Year Real World Outcomes

Maria Eleftheriadou; Clara Vazquez-Alfageme; Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Sobha Sivaprasad; Philip Hykin; Robin D Hamilton; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3355. doi:

Advertisement